2m 2m 2m 2m 2m 2m 2m
CEL-SCI (CVM)
NYSE
$1.48$0.00 (0.00%)
Price as of Jun 03, 2026 6:02 PM EDT- $22.3MMarket Cap
- -38.59%1-Year Change
- BiotechnologyIndustry
CEL-SCI (CVM)
$1.48$0.00 (0.00%)
Annual
Quarterly
09/30/2025 | 09/30/2024 | 09/30/2023 | 09/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | -648,944 N/A | N/A N/A | 6,000 +100.56% | -1.1M -5.94% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | -648,944 N/A | 0 -100.00% | 6,000 +100.56% | -1.1M -5.94% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -15.9M -12.52% | -18.2M -19.18% | -22.5M -11.37% | -25.4M +9.72% | |
Depreciation and Amortization Expense | 3.9M -2.12% | 4.0M +0.27% | 4.0M +3.38% | 3.8M +71.62% | |
Total Operating Expenses | 24.8M -5.85% | 26.4M -16.28% | 31.5M -12.72% | 36.1M -0.36% | |
Operating Profit | -24.8M -5.85% | -26.4M -16.28% | -31.5M -12.72% | -36.1M -0.36% | |
Interest Income | N/A N/A | N/A N/A | 0 -100.00% | 615 N/A | |
Interest Expense | -648,944 -12.97% | -745,673 +10.40% | -675,416 -37.52% | -1.1M -5.94% | |
Interest Income and Expense and Net | -648,944 -12.97% | -745,673 +10.40% | -675,416 -37.49% | -1.1M -5.99% | |
Total Nonoperating Income and Expense | 47,625 -73.20% | 177,682 +515.02% | -42,813 -139.96% | 107,148 +1,404.61% | |
Income before Taxes | -25.4M -3.57% | -26.4M -18.58% | -32.4M -13.99% | -37.6M +2.50% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -25.4M -7.86% | -27.6M -14.33% | -32.2M -12.28% | -36.7M +0.93% | |
Net Income from Continuing Operations Applicable to Common | -25.4M -7.86% | -27.6M -14.79% | -32.4M -13.99% | -37.6M +2.50% | |
Basic EPS and Net Income | N/A N/A | N/A N/A | N/A N/A | -0.87 -3.33% | |
Diluted EPS and Net Income | -6.27 +1,129.41% | -0.51 N/A | N/A N/A | -0.87 -6.45% | |
Basic Weighted Average Shares | 4.1M -92.50% | 54.0M +21.50% | 44.5M +3.08% | 43.1M +6.12% | |
Diluted Weighted Average Shares | 4.1M -92.50% | 54.0M +21.50% | 44.5M +3.08% | 43.1M +6.03% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 11.0M +131.17% | 4.7M +14.29% | 4.1M -81.71% | 22.7M -37.13% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Cash and Cash Equivalents and Short-Term Investments | 11.0M +131.17% | 4.7M +14.29% | 4.1M -81.71% | 22.7M -46.29% | |
Total Current Assets | 11.6M +91.49% | 6.1M -12.47% | 6.9M -72.80% | 25.4M -43.81% | |
Accumulated Depreciation | 12.1M +19.79% | 10.1M +26.71% | 7.9M +35.82% | 5.8M +42.24% | |
Property and Plant and Equipment and Net | 6.1M -25.22% | 8.1M -20.20% | 10.2M -14.31% | 11.9M -12.99% | |
Total Long-Term Assets | 6.1M -25.22% | 8.1M -20.20% | 10.2M -14.31% | 11.9M -12.99% | |
Total Assets | 28.2M +4.31% | 27.0M -11.58% | 30.5M -39.58% | 50.5M -33.41% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 2.3M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 5.1M +11.15% | 4.6M -17.37% | 5.6M +19.77% | 4.7M +18.46% | |
Total Long-Term Debt | 5.7M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 125,000 0.00% | 125,000 0.00% | 125,000 0.00% | 125,000 0.00% | |
Total Liabilities | 12.2M -13.64% | 14.1M -18.42% | 17.3M -5.70% | 18.4M -5.04% | |
Retained Earnings | -539.4M +4.94% | -514.0M +5.53% | -487.1M +7.08% | -454.9M +8.78% | |
Total Stockholders Equity | 16.0M +24.01% | 12.9M -2.63% | 13.2M -58.91% | 32.2M -43.11% | |
Total Shares Outstanding | 8.0M -87.43% | 63.8M +34.51% | 47.4M +9.15% | 43.4M +0.56% | |
Cash Flow | |||||
Cash from Operating Activities | -17.1M -8.99% | -18.8M -17.67% | -22.8M +25.26% | -18.2M -2.91% | |
Capital Expenditures | 38,109 -59.83% | 94,875 -73.78% | 361,892 -43.27% | 637,892 -92.93% | |
Cash from Investing Activities | -38,109 -64.74% | -108,086 -70.97% | -372,262 -106.78% | 5.5M +136.16% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 23.4M +19.79% | 19.5M +315.64% | 4.7M +835.31% | -638,426 -101.17% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 3,823.09% N/A | N/A N/A | -524,601.23% -15,825.68% | 3,335.95% +5.93% | |
Return on Assets | -92.16% -3.90% | -95.90% +20.71% | -79.44% +36.79% | -58.07% -7.04% | |
Return on Equity | -176.32% -16.63% | -211.49% +49.05% | -141.89% +71.46% | -82.75% -13.22% | |
Revenue Growth | N/A N/A | N/A N/A | 100.56% +1,593.19% | 5.94% +157.52% | |
Current Ratio | 2.26 +72.27% | 1.31 +5.93% | 1.24 -77.29% | 5.45 -52.57% | |
Cash Ratio | 2.14 +107.99% | 1.03 +38.31% | 0.74 -84.73% | 4.86 -46.92% | |
Debt-to-Equity Ratio | 0.50 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.28 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow